ENTERA BIO IS-0000769 Financial Flexibility Index
ENTERA BIO IS-0000769 financial flexibility index. ENTERA BIO IS-0000769 (5DT) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of €-3.46 Million (operating CF €-3.46 Million minus capex €0.00) represents 0% of total liabilities (€12.21 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ENTERA BIO IS-0000769 (2021–2025)
Financial flexibility index of ENTERA BIO IS-0000769 from 2021 to 2025. Historical Financial Flexibility Index trend for ENTERA BIO IS-0000769 across 5 annual periods. Explore ENTERA BIO IS-0000769 (5DT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
ENTERA BIO IS-0000769 Financial Flexibility Index by Year (2021–2025)
ENTERA BIO IS-0000769 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for ENTERA BIO IS-0000769. For the full cash flow conversion analysis, see ENTERA BIO IS-0000769 (5DT) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.51x | €-7.26 Million | €-7.37 Million | €2.89 Million | ▲ +51.7% |
| 2024 | -5.20x | €-6.82 Million | €-6.82 Million | €1.31 Million | ▲ +1.6% |
| 2023 | -5.29x | €-7.29 Million | €-7.31 Million | €1.38 Million | ▲ +41.7% |
| 2022 | -9.07x | €-12.45 Million | €-12.50 Million | €1.37 Million | ▼ -243.1% |
| 2021 | -2.64x | €-9.05 Million | €-9.06 Million | €3.42 Million | — |